Dr Nicholas Draeger
A scientist, chemical engineer, financial expert and entrepreneur, Nicholas started his career at
Roche Pharmaceuticals in Research and later in Global Business Development focusing on M&A and licensing. At the Italian pharmaceutical company, Recordati, he was Director of International Business Development. Later, Nicholas moved into the finance sector at the French finance group, Credit Agricole Indosuez Cheuvreux as head of the Biotech broker team. Nicholas was a member of the management team of BB Biotech and later portfolio manager at Adamant Biomedical Investments both in Switzerland, specialising in investments in Australia, Asia and South Africa, and venture capital.
Nicholas is a Founder and Director of Cederberg GmbH, a Swiss pharmaceutical marketing and
distribution company, and Founder of Nurevas International, a food (and fortified foods)
production and marketing company, with operations in Switzerland and Ghana and with sales
across West Africa. He is an Entrepreneur in Residence to Lancaster University in both the U.K.
and Ghana, an Entrepreneur in Residence to Emory University in the US and a mentor to the
NHS Clinical Entrepreneur programme in the UK amongst other responsibilities. He is a Director and Chief Strategy Officer at the Eugene Gasana Jr Foundation. Nicholas currently advises a number of young enterprises around the world on strategy, financing and operations. Nicholas’s primary interests lie in healthcare and nutrition.
Nicholas holds a Bsc (Hons) in Chemical Engineering from the University of Natal, South Africa, a PhD from the University of Cambridge, UK, in Biochemical Engineering, and an MBA from the
University of Warwick, UK.